Which Emerging Trends Are Driving The Neuropathic Pain Market Toward $7.78 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Neuropathic Pain Market?
The market size of neuropathic pain has shown robust growth in the past few years. It’s projected to increase from $5.35 billion in 2024 to $5.78 billion in 2025, registering a compound annual growth rate (CAGR) of 7.9%. The historical growth is largely due to the rising need for neuropathic pain medications, an epidemic of chronic pain, expanding demand for prescribed treatments, and governmental strategies.
Looking towards the future, the market size for neuropathic pain is anticipated to witness robust expansion in the years to come. The market is projected to increase to a valuation of $7.78 billion by 2029, ballooning at a compound annual growth rate (CAGR) of 7.7%. The surge in the forecasted period can be credited to the increased awareness about neuropathic pain, an older population demographic, a thriving healthcare sector, and easier access to treatments for neuropathic pain. Prime trends that will punctuate the forecasted period encompass better diagnostic measures, progressive development in pain management, medical research advancements, approval for new pharmaceuticals, and strategic initiatives.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12922&type=smp
What Core Drivers Are Expected To Influence The Neuropathic Pain Market?
The neuropathic pain market is predicted to expand due to the increasing occurrences of chronic pain. Chronic pain is a lingering discomfort that exceeds the anticipated recovery period of an injury or disease, typically persisting for at least three to six months or longer. The escalating incidence of chronic pain, including neuropathic disorders, necessitates potent treatment options, thereby motivating research, innovation, and investment towards bettering therapies to heighten symptom alleviation and life quality. For example, the Scottish Health Survey 2022, published by the Scottish Government in December 2023, revealed that in 2022, over a third (38%) of Scotland’s adults reported suffering from pain or discomfort persisting three months or longer. The prevalence was notably higher among women (43%) as compared to men (33%). Therefore, the escalating occurrence of chronic pain is fueling the growth of the neuropathic pain market.
What Are The Main Segment Classifications In The Neuropathic Pain Market?
The neuropathic painmarket covered in this report is segmented –
1) By Treatment: Medications; Multimodal Therapy
2) By Diagnosis: Imaging; Blood Tests And Physical Examination
3) By Indication: Diabetic Neuropathy; Spinal Stenosis; Chemotherapy-Induced Peripheral Neuropathy; Other Indications
4) By End User: Hospitals; Clinics; Home Healthcare; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Medications: Anticonvulsants; Antidepressants; Opioids; Topical Treatments; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Multimodal Therapy: Combination Of Medications; Physical Therapy; Psychological Therapy; Lifestyle Modifications; Complementary Therapies
How Are Market Trends Influencing Competition In The Neuropathic Pain Market?
Artificial intelligence technologies are being embraced by leading companies active in the neuropathic pain market, using them for enhanced diagnostics, personalized treatment protocols, real-time patient monitoring, drug creation, and analysis informed by accurate data to improve patient results and fine-tune pain management techniques. For instance, Nevro Corp., an American medical device firm, unveiled the Senza HFX iQ spinal cord stimulation (SCS) system in March 2023. This breakthrough technology uses AI to provide bespoke pain relief for each patient. The holistic system, inclusive of elements like the HFX iQ Implantable Pulse Generator (IPG), HFX Trial Stimulator, Charger, and HFX App, has been built to manage non-surgical back pain and painful diabetic neuropathy by responding to patient signals. Using a unique algorithm grounded in wide-ranging patient data, it authorizes patients to tweak their pain relief routine through an intuitive smartphone application. The system’s digital platform facilitates data aggregation and possible updates. The technology focuses on boosting pain relief with replicable consistency and personal adaptation, representing a substantial progression in SCS treatment.
Which Companies Are Contributing Significantly To The Neuropathic Pain Market Growth?
Major companies operating in the neuropathic pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Medtronic Inc., Eli Lilly and Company, Stryker Corporation, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Biogen Inc., Zimmer Biomet Holdings Inc., Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., NuVasive Inc., Integer Holdings Corporation, Avanos Medical Inc., Orthofix Medical Inc., Nevro Corp., InvaGen Pharmaceuticals Inc., B. Braun Melsungen AG, Cirtec Medical Corp., Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, DePuy Synthes.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report
Which Region Holds The Greatest Opportunity For Neuropathic Pain Market Expansion?
North America was the largest region in the neuropathic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuropathic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12922&type=smp
Browse Through More Reports Similar to the Global Neuropathic Pain Market 2025, By The Business Research Company
Generic Central Nervous System Drugs Global Market Report 2025
Nerve Repair And Regenerative Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report
Central Nervous System Biomarkers Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
